Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2026-02-09 @ 9:02 AM
Study NCT ID:
NCT02097303
Status:
COMPLETED
Last Update Posted:
2018-02-01
First Post:
2014-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis
Sponsor:
Carolina Research Professionals, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03
Start Date Type:
None
Primary Completion Date:
2015-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-21
First Submit QC Date:
None
Study First Post Date:
2014-03-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-01-22
Results First Submit QC Date:
None
Results First Post Date:
2018-02-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-22
Last Update Post Date:
2018-02-01
Last Update Post Date Type:
ACTUAL